How frequently does necrosis occur in untreated breast cancer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Frequency of Necrosis in Untreated Breast Cancer

Necrosis occurs in approximately 50-56% of invasive breast cancers, with higher rates in larger, more aggressive tumors—particularly those exceeding 360 microns (180 microns radius) in diameter, where necrosis is present in 94% of cases.

Evidence-Based Frequency

The available research provides specific quantitative data on necrosis frequency in breast cancer:

  • Invasive ductal carcinoma: A morphometric study found necrosis in 56% of intraductal breast carcinomas 1. This represents a substantial proportion of untreated disease.

  • Size-dependent occurrence: Necrosis demonstrates a clear relationship with tumor size. In ducts less than 180 microns in radius, only 34% contained necrosis, whereas 94% of ducts exceeding 180 microns in radius showed central necrosis 1. The mean diameter of ducts with necrosis was 470 microns compared to 192 microns for solid tumors without necrosis 1.

Pathophysiologic Mechanism

The development of necrosis follows a predictable pattern related to tumor growth outpacing vascular supply:

  • Hypoxic compartments: The viable tumor tissue rim surrounding necrotic areas measures less than 180 microns in 91% of cases 1, analogous to findings in lung tumor cords and providing evidence for hypoxic compartments.

  • Paradoxical vascular relationship: Contrary to earlier assumptions, necrosis occurs in tumors with high focal vascular density rather than poor overall blood supply 2. The necrosis develops in areas away from these highly vascularized regions due to vascular shunting, which exacerbates regional ischemia.

  • Hypoxia markers: Over 90% of necrotic tumors express at least one hypoxia marker (HIF1, CA IX, or GLUT1), though notably, 30% of non-necrotic tumors also show hypoxia marker expression 3.

Clinical Associations and Prognostic Implications

Necrosis correlates with aggressive tumor biology:

  • Tumor characteristics: Necrosis associates with high tumor grade, larger size, low estrogen receptor status, and increased macrophage infiltration 2

  • Angiogenesis relationship: Significant correlation exists between necrosis degree and both macrophage infiltration (p=0.0009) and angiogenesis (p=0.0008) 2

Important Clinical Caveats

The provided guidelines 4, 5 do not address untreated breast cancer or necrosis frequency, as modern oncology practice emphasizes immediate treatment. The natural history data comes from research studies examining tumor biology rather than clinical management recommendations.

The question of "untreated" breast cancer is largely academic in contemporary practice, as breast cancer treatment is standard of care immediately upon diagnosis to prevent morbidity and mortality.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.